Logo image of HPCO

HEMPACCO CO INC (HPCO) Stock Fundamental Analysis

NASDAQ:HPCO - Nasdaq - US42371L2051 - Common Stock - Currency: USD

0.6201  -0.05 (-7.46%)

After market: 0.5581 -0.06 (-10%)

Fundamental Rating

1

Overall HPCO gets a fundamental rating of 1 out of 10. We evaluated HPCO against 8 industry peers in the Tobacco industry. Both the profitability and financial health of HPCO have multiple concerns. HPCO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HPCO has reported negative net income.
In the past year HPCO has reported a negative cash flow from operations.
HPCO Yearly Net Income VS EBIT VS OCF VS FCFHPCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

HPCO has a Return On Assets of -72.75%. This is amonst the worse of the industry: HPCO underperforms 80.00% of its industry peers.
Industry RankSector Rank
ROA -72.75%
ROE N/A
ROIC N/A
ROA(3y)-60.38%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HPCO Yearly ROA, ROE, ROICHPCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 1K 2K 3K

1.3 Margins

HPCO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HPCO Yearly Profit, Operating, Gross MarginsHPCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

0

2. Health

2.1 Basic Checks

HPCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HPCO has more shares outstanding
Compared to 1 year ago, HPCO has a worse debt to assets ratio.
HPCO Yearly Shares OutstandingHPCO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
HPCO Yearly Total Debt VS Total AssetsHPCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

HPCO has an Altman-Z score of -3.66. This is a bad value and indicates that HPCO is not financially healthy and even has some risk of bankruptcy.
HPCO has a Altman-Z score of -3.66. This is amonst the worse of the industry: HPCO underperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.66
ROIC/WACCN/A
WACC5.02%
HPCO Yearly LT Debt VS Equity VS FCFHPCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M -2M 4M -4M 6M -6M

2.3 Liquidity

HPCO has a Current Ratio of 0.25. This is a bad value and indicates that HPCO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.25, HPCO is doing worse than 90.00% of the companies in the same industry.
HPCO has a Quick Ratio of 0.25. This is a bad value and indicates that HPCO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.06, HPCO is doing worse than 90.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.06
HPCO Yearly Current Assets VS Current LiabilitesHPCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for HPCO have decreased strongly by -55.51% in the last year.
The Revenue has been growing slightly by 1.97% in the past year.
Measured over the past years, HPCO shows a very strong growth in Revenue. The Revenue has been growing by 126.97% on average per year.
EPS 1Y (TTM)-55.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.46%
Revenue 1Y (TTM)1.97%
Revenue growth 3Y126.97%
Revenue growth 5YN/A
Sales Q2Q%285.83%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HPCO Yearly Revenue VS EstimatesHPCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 1M 2M 3M 4M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

HPCO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HPCO Price Earnings VS Forward Price EarningsHPCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HPCO Per share dataHPCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HPCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEMPACCO CO INC

NASDAQ:HPCO (9/5/2024, 8:00:02 PM)

After market: 0.5581 -0.06 (-10%)

0.6201

-0.05 (-7.46%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)11-15 2022-11-15/bmo
Earnings (Next)N/A N/A
Inst Owners0.49%
Inst Owner Change-1.74%
Ins Owners7.37%
Ins Owner Change0%
Market Cap3.67M
AnalystsN/A
Price TargetN/A
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.91
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.59
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.06
FCFYN/A
OCF(TTM)-0.99
OCFYN/A
SpS0.68
BVpS-0.06
TBVpS-0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -72.75%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-60.38%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 102.84%
Cap/Sales 10.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.06
Altman-Z -3.66
F-Score3
WACC5.02%
ROIC/WACCN/A
Cap/Depr(3y)100.85%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.97%
Revenue growth 3Y126.97%
Revenue growth 5YN/A
Sales Q2Q%285.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-56.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-39.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.73%
OCF growth 3YN/A
OCF growth 5YN/A